TherapeuticsMD, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized
TherapeuticsMD, Inc. (TXMD) had Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized of 13.78 million shares as of 2019-09-30, per its 10-Q filed 2019-11-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized · last filed 2019-11-08
- 2019-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 13.78M shares.
- 2019-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 16.81M shares.
- 2012-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 25.00M shares.
- 2012-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 25.00M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized |
|---|---|
| 2019-09-30 | 13.78M shares 10-Q · filed 2019-11-08 |
| 2019-06-30 | 16.81M shares 10-Q · filed 2019-08-09 |
| 2012-09-30 | 25.00M shares 10-Q · filed 2012-11-13 |
| 2012-06-30 | 25.00M shares 10-Q · filed 2012-08-09 |
| 2011-07-29 | 25.00M shares 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |